Skip to main content
NCBI home page
Heart logoLink to Heart
editorial
. 1996 Feb;75(2):111–113. doi: 10.1136/hrt.75.2.111

Class III Antiarrhythmics: put to the SWORD?

S M Cobbe
PMCID: PMC484241  PMID: 8673743

Full text

PDF
111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama T., Pawitan Y., Greenberg H., Kuo C. S., Reynolds-Haertle R. A. Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol. 1991 Dec 15;68(17):1551–1555. doi: 10.1016/0002-9149(91)90308-8. [DOI] [PubMed] [Google Scholar]
  2. Bayés de Luna A., Coumel P., Leclercq J. F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989 Jan;117(1):151–159. doi: 10.1016/0002-8703(89)90670-4. [DOI] [PubMed] [Google Scholar]
  3. Belkić K., Ercegovac D., Savić C., Panić B., Djordjević M., Savić S. EEG arousal and cardiovascular reactivity in professional drivers: the glare pressor test. Eur Heart J. 1992 Mar;13(3):304–309. doi: 10.1093/oxfordjournals.eurheartj.a060167. [DOI] [PubMed] [Google Scholar]
  4. Bigger J. T., Jr, Fleiss J. L., Kleiger R., Miller J. P., Rolnitzky L. M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984 Feb;69(2):250–258. doi: 10.1161/01.cir.69.2.250. [DOI] [PubMed] [Google Scholar]
  5. Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol. 1990 Dec;16(7):1711–1718. doi: 10.1016/0735-1097(90)90324-i. [DOI] [PubMed] [Google Scholar]
  6. Ceremuzynski L., Kleczar E., Krzeminska-Pakula M., Kuch J., Nartowicz E., Smielak-Korombel J., Dyduszynski A., Maciejewicz J., Zaleska T., Lazarczyk-Kedzia E. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol. 1992 Nov 1;20(5):1056–1062. doi: 10.1016/0735-1097(92)90357-s. [DOI] [PubMed] [Google Scholar]
  7. Doval H. C., Nul D. R., Grancelli H. O., Perrone S. V., Bortman G. R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet. 1994 Aug 20;344(8921):493–498. doi: 10.1016/s0140-6736(94)91895-3. [DOI] [PubMed] [Google Scholar]
  8. Echt D. S., Liebson P. R., Mitchell L. B., Peters R. W., Obias-Manno D., Barker A. H., Arensberg D., Baker A., Friedman L., Greene H. L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21;324(12):781–788. doi: 10.1056/NEJM199103213241201. [DOI] [PubMed] [Google Scholar]
  9. El-Sherif N., Scherlag B. J., Lazzara R., Hope R. R. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine. Circulation. 1977 Sep;56(3):395–402. doi: 10.1161/01.cir.56.3.395. [DOI] [PubMed] [Google Scholar]
  10. Goldstein S., Medendorp S. V., Landis J. R., Wolfe R. A., Leighton R., Ritter G., Vasu C. M., Acheson A. Analysis of cardiac symptoms preceding cardiac arrest. Am J Cardiol. 1986 Dec 1;58(13):1195–1198. doi: 10.1016/0002-9149(86)90380-2. [DOI] [PubMed] [Google Scholar]
  11. Hicks M. N., Cobbe S. M. Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol. Cardiovasc Res. 1990 May;24(5):404–410. doi: 10.1093/cvr/24.5.404. [DOI] [PubMed] [Google Scholar]
  12. Jazayeri M. R., Van Wyhe G., Avitall B., McKinnie J., Tchou P., Akhtar M. Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1989 Sep;14(3):705–714. doi: 10.1016/0735-1097(89)90114-9. [DOI] [PubMed] [Google Scholar]
  13. Julian D. G., Prescott R. J., Jackson F. S., Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982 May 22;1(8282):1142–1147. doi: 10.1016/s0140-6736(82)92225-5. [DOI] [PubMed] [Google Scholar]
  14. Kleiger R. E., Miller J. P., Bigger J. T., Jr, Moss A. J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987 Feb 1;59(4):256–262. doi: 10.1016/0002-9149(87)90795-8. [DOI] [PubMed] [Google Scholar]
  15. La Rovere M. T., Specchia G., Mortara A., Schwartz P. J. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation. 1988 Oct;78(4):816–824. doi: 10.1161/01.cir.78.4.816. [DOI] [PubMed] [Google Scholar]
  16. Lenfant C. NHLBI funding policies. Enhancing stability, predictability, and cost control. Circulation. 1994 Jul;90(1):1–1. doi: 10.1161/01.cir.90.1.1. [DOI] [PubMed] [Google Scholar]
  17. Mason J. W. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993 Aug 12;329(7):452–458. doi: 10.1056/NEJM199308123290702. [DOI] [PubMed] [Google Scholar]
  18. Morganroth J., Goin J. E. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation. 1991 Nov;84(5):1977–1983. doi: 10.1161/01.cir.84.5.1977. [DOI] [PubMed] [Google Scholar]
  19. Myerburg R. J., Conde C. A., Sung R. J., Mayorga-Cortes A., Mallon S. M., Sheps D. S., Appel R. A., Castellanos A. Clinical, electrophysiologic and hemodynamic profile of patients resuscitated from prehospital cardiac arrest. Am J Med. 1980 Apr;68(4):568–576. doi: 10.1016/0002-9343(80)90307-1. [DOI] [PubMed] [Google Scholar]
  20. Pfisterer M., Kiowski W., Burckhardt D., Follath F., Burkart F. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol. 1992 Jun 1;69(17):1399–1402. doi: 10.1016/0002-9149(92)90889-7. [DOI] [PubMed] [Google Scholar]
  21. Sager P. T., Follmer C., Uppal P., Pruitt C., Godfrey R. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Circulation. 1994 Oct;90(4):1811–1819. doi: 10.1161/01.cir.90.4.1811. [DOI] [PubMed] [Google Scholar]
  22. Steinbeck G., Andresen D., Bach P., Haberl R., Oeff M., Hoffmann E., von Leitner E. R. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992 Oct 1;327(14):987–992. doi: 10.1056/NEJM199210013271404. [DOI] [PubMed] [Google Scholar]
  23. Tande P. M., Refsum H. Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation. Pharmacol Toxicol. 1988 May;62(5):272–277. doi: 10.1111/j.1600-0773.1988.tb01886.x. [DOI] [PubMed] [Google Scholar]
  24. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES